Archives

by in
Entry Author Date Location
Bay Area Biotech Startup at Odds with Dana-Farber and Novartis Over Cancer Drug Rights 10/28/10 Boston
Agios Adds Alnylam Chief to Board 06/24/10 Boston
Genzyme Annual Meeting Remarkably Mundane, Despite Rocky Year 06/16/10 Boston
Genzyme Borrows $1B for Stock Buyback 06/15/10 Boston
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote 06/09/10 Boston
Genzyme Taps Amgen Vet for Board 06/07/10 Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders 05/13/10 Boston
Phase Forward Offering Pharmas One-Stop Shopping for Clinical Research Software 03/09/10 Boston
Millipore Taps Langer for Board Seat 12/16/09 Boston
Synageva Finishes $45M Round 10/20/09 Boston
Another Biogen Director to Retire 08/26/09 Boston
Page 1 of 1